author-photo

Tomas G. Lyons

Memorial Sloan Kettering Cancer Center

4

Papers

78

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (3)
Emerging Novel Therapeutics in Triple-Negative Breast Cancer

2019 Advances in Experimental Medicine and Biology
- Tomas G. Lyons
- Tiffany A. Traina
Show All
- Source
- Cite
- Save
Citations (13)
Targeted Therapies for Triple-Negative Breast Cancer

2019 Current Treatment Options in Oncology
- Tomas G. Lyons
Show All
- Source
- Cite
- Save
Citations (61)